Topics

Glioblastoma | Treatment | Chemotherapy | Temozolomide | Safety assessment

Home > Publications > Topics > Glioblastoma > Treatment > Chemotherapy > Temozolomide > Safety assessment

Liu Y, Ma L, Fu X, Zhang Y, Zheng J, Chen Z.
Safety assessment of temozolomidee: real-world adverse event analysis from the FAERS database.
Front Pharmacol. 2025 Aug 6;16:1578406. doi: 10.3389/fphar.2025.1578406. PMID: 40843381. Observational study. ˍ